TipRanks
Advertisement
Advertisement

MANE Stock Latest News

Buy/High Risk Rating Reiterated on MANE as Phase 3 Hair Loss Catalyst Nears; $160 Price Target Maintained
RatingsBuy/High Risk Rating Reiterated on MANE as Phase 3 Hair Loss Catalyst Nears; $160 Price Target Maintained
17d ago
MANE
Citi opens ‘upside 90-day catalyst watch’ on Veradermics into data
PremiumThe Fly
Citi opens ‘upside 90-day catalyst watch’ on Veradermics into data
17d ago
MANE
Buy Rating Reaffirmed on Strong VDPHL01 Data and Catalyst-Rich Roadmap; Price Target Maintained at $164
PremiumRatings
Buy Rating Reaffirmed on Strong VDPHL01 Data and Catalyst-Rich Roadmap; Price Target Maintained at $164
2M ago
MANE
Veradermics sees cash runway into 2030
PremiumThe Fly
Veradermics sees cash runway into 2030
2M ago
MANE
Veradermics reports Q2 net loss ($23.5M) vs. ($15.6M) last year
PremiumThe Fly
Veradermics reports Q2 net loss ($23.5M) vs. ($15.6M) last year
2M ago
MANE
Veradermics registers to sell 16.77M shares of common stock
PremiumThe FlyVeradermics registers to sell 16.77M shares of common stock
2M ago
MANE
Veradermics presents data from subgroup analysis of Phase 2/3 VDPHL01 study
Premium
The Fly
Veradermics presents data from subgroup analysis of Phase 2/3 VDPHL01 study
3M ago
MANE
Veradermics price target raised to $160 from $135 at Citi
Premium
The Fly
Veradermics price target raised to $160 from $135 at Citi
3M ago
MANE
B. Riley Analyst Initiates Coverage of Veradermics Stock (MANE) With a Buy Rating
PremiumMarket News
B. Riley Analyst Initiates Coverage of Veradermics Stock (MANE) With a Buy Rating
3M ago
MANE
Veradermics rises 13.9%
PremiumThe Fly
Veradermics rises 13.9%
3M ago
MANE
Fifteen new option listings on July 15th
PremiumThe Fly
Fifteen new option listings on July 15th
3M ago
AKTS
AVBC
Veradermics announces results from Phase 2 trial of VDPHL01
PremiumThe Fly
Veradermics announces results from Phase 2 trial of VDPHL01
3M ago
MANE
Veradermics initiated with a Buy at B. Riley
PremiumThe FlyVeradermics initiated with a Buy at B. Riley
3M ago
MANE
Veradermics price target raised to $182 from $138 at Jefferies
Premium
The Fly
Veradermics price target raised to $182 from $138 at Jefferies
3M ago
MANE
Veradermics initiated with an Outperform at LifeSci Capital
Premium
The Fly
Veradermics initiated with an Outperform at LifeSci Capital
4M ago
MANE
Veradermics initiated with a Buy at Needham
PremiumThe Fly
Veradermics initiated with a Buy at Needham
4M ago
MANE
PremiumRatings
Veradermics Initiated at Buy on Late-Stage Oral Hair Loss Therapy VDPHL01 and Multi-Billion-Dollar Peak Sales Potential
4M ago
MANE
Veradermics price target raised to $135 from $120 at Citi
PremiumThe Fly
Veradermics price target raised to $135 from $120 at Citi
5M ago
MANE
PremiumCompany Announcements
Veradermics Faces Financing Risk as Cashless Pre-Funded Warrants Offer Little to No Capital Infusion
5M ago
MANE
Veradermics reports Q1 net income ($27.2M) vs ($12.4M) last year
PremiumThe FlyVeradermics reports Q1 net income ($27.2M) vs ($12.4M) last year
5M ago
MANE
Premium
Company Announcements
Veradermics Boosts Capital Through Public Offering and Warrants
5M ago
8K
MANE
Veradermics 3.84M share Secondary priced at $100.00
Premium
The Fly
Veradermics 3.84M share Secondary priced at $100.00
5M ago
MANE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >